-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Lymph node dissection in minimally invasive esophagectomy is a central part of curative treatment for locally advanced esophageal cancer. Removing the esophagus without addressing regional lymphatic disease can leave behind microscopic metastases and limit accurate pathological staging.
The procedure combines oncological principles with thoracoscopic and laparoscopic techniques. Smaller incisions may reduce chest wall trauma, yet the operation remains technically demanding because lymphatic tissue lies close to the trachea, recurrent laryngeal nerves, major vessels, and thoracic duct.
Educational programs such as the ISDE 2021 World Congress provide an important setting for discussing surgical anatomy, operative videos, pathology standards, and evolving evidence. Decisions about nodal clearance should be made within a multidisciplinary team and adapted to tumor location, histology, clinical stage, and the patient’s condition.
Esophageal cancer spreads through longitudinal lymphatic channels, so metastases may appear above or below the primary tumor. A thorough regional lymphadenectomy improves staging accuracy and can contribute to locoregional control when performed with an appropriate esophagectomy.
The required field depends on tumor position and biology. Squamous cell carcinoma, particularly in the upper or middle thoracic esophagus, may have a wider cervical and mediastinal spread pattern. Adenocarcinoma near the esophagogastric junction more often emphasizes lower mediastinal and abdominal nodes, although individual patterns vary.
Preoperative planning integrates contrast-enhanced CT, PET-CT, endoscopic ultrasound when appropriate, and the findings from endoscopic biopsy. Neoadjuvant chemotherapy or chemoradiotherapy can alter nodal size and tissue planes, but radiographic response does not reliably exclude residual microscopic disease.
The operative plan should define the intended lymphadenectomy before incision. Important choices include transthoracic or transhiatal access, the number of fields, the reconstruction route, and whether cervical nodes require attention. Patient frailty, pulmonary reserve, previous treatment, and institutional expertise also influence the safest approach.
A two-field dissection generally includes abdominal and thoracic lymph nodes. The thoracic component may cover paraesophageal, subcarinal, lower paratracheal, and other mediastinal stations, while the abdominal component commonly includes perigastric and celiac-axis nodes relevant to the tumor location.
Three-field lymphadenectomy adds cervical nodal clearance. It can be considered for selected patients with upper or middle esophageal tumors, suspected cervical or recurrent laryngeal nerve chain involvement, or histological patterns associated with broader lymphatic spread. The additional field may increase operative time and risks such as recurrent nerve injury.
Minimally invasive esophagectomy can achieve an oncologically appropriate lymph node yield when surgeons have suitable experience and use a structured technique. The approach should be judged by completeness of dissection, quality of the specimen, morbidity, and long-term outcomes rather than incision size alone.
| Approach | Typical nodal emphasis | Potential advantages | Important concerns |
|---|---|---|---|
| Ivor Lewis | Abdominal and lower or middle mediastinal nodes | Intrathoracic anastomosis and effective thoracoabdominal access | Anastomotic leak, mediastinal dissection complexity |
| McKeown | Abdominal, thoracic, and cervical nodes | Useful when a cervical anastomosis or wider field is planned | Longer operation and possible recurrent nerve injury |
| Transhiatal | Abdominal and lower mediastinal nodes without formal thoracotomy | Avoids a thoracic incision in selected patients | Limited access to upper and middle mediastinal nodes |
| Robotic or advanced thoracoscopic technique | Depends on the planned field | Enhanced visualization and instrument articulation | Learning curve, cost, and dependence on team expertise |
Thoracoscopic dissection requires clear identification of the esophagus and surrounding planes before dividing lymphatic tissue. The surgeon must protect the tracheobronchial tree, aorta, azygos system, thoracic duct, and recurrent laryngeal nerves. Careful energy use is important near delicate nerves and major vessels.
The abdominal phase includes mobilization of the stomach while preserving an adequate right gastroepiploic blood supply for the conduit. Celiac, left gastric, common hepatic, and splenic artery nodal tissue is assessed according to tumor location and the planned oncological field. Specimens should be oriented and submitted separately when this supports accurate pathological mapping.
More extensive lymphadenectomy may improve staging and local control in carefully selected patients, but increased dissection can raise the likelihood of pulmonary complications, vocal cord dysfunction, bleeding, and chyle leak. The goal is a complete, anatomically appropriate clearance rather than indiscriminate removal of every accessible node.
Anastomotic integrity, pulmonary recovery, pain control, and early mobilization remain essential measures of success. Enhanced recovery pathways, lung-protective ventilation, nutritional planning, and early recognition of recurrent laryngeal nerve dysfunction can help reduce the overall burden of surgery.
The final report should document the total number of examined nodes, involved nodes, tumor regression, margins, and treatment effect. Nodal ratio and the distribution of positive stations may provide additional prognostic information, although interpretation depends on the staging system and the quality of the specimen.
Surgeons and pathologists should communicate about specimen orientation and suspicious tissue found during the operation. Multidisciplinary review of the pathological findings helps determine surveillance, adjuvant treatment, and the value of additional molecular or clinical investigation.
Review the scientific sessions, surgical education materials, and esophageal disease research presented through ISDE 2021 to place minimally invasive lymphadenectomy within the wider development of modern esophageal cancer care.